Gilbert, Adam M <br/><br/>
Recent advances in irreversible kinase inhibitors.  [electronic resource] 

 -  Pharmaceutical patent analyst  Jul 2014 
 - 375-86 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>2046-8962 
<br/><br/><label>Standard No.: </label>10.4155/ppa.14.24  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Agammaglobulinaemia Tyrosine Kinase<br/>Arthritis, Rheumatoid--drug therapy<br/>Autoimmune Diseases--drug therapy<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>ErbB Receptors--antagonists & inhibitors<br/>Graft Rejection--drug therapy<br/>Humans<br/>Inflammatory Bowel Diseases--drug therapy<br/>Janus Kinase 3--antagonists & inhibitors<br/>Lymphoma, B-Cell--drug therapy<br/>Lymphoma, Mantle-Cell--drug therapy<br/>Neoplasm Metastasis--drug therapy<br/>Patents as Topic<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Protein Kinase Inhibitors--chemistry<br/>Protein-Tyrosine Kinases--antagonists & inhibitors